Neuphoria Therapeutics regains Nasdaq minimum bid price compliance

Neuphoria Therapeutics Inc.

Received Nasdaq letter confirming compliance with Minimum Bid Price Rule 5450(a)(1) on Jan 10, 2025.
Common stock (NEUP) closed at $1.00 or higher for 10 consecutive business days from Dec 24, 2024 to Jan 8, 2025.
Deficiency letter previously disclosed in July 2024; compliance deadline was Jan 7, 2025.
Matter is now closed; company avoids potential delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.